| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/27/2009 | CN100490808C Gliquilone slow-releasing preparation |
| 05/27/2009 | CN100490807C Cephalofruxin ester liposome, its preparation and medicinal composition containing it |
| 05/27/2009 | CN100490806C Oral dispersion domperidone coutrolled-release gel and its preparing method |
| 05/27/2009 | CN100490805C Composition for the transdermal delivery of fentanyl |
| 05/27/2009 | CN100490804C Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 05/27/2009 | CN100490803C Autoemulsified albendazole preparation and its preparation process |
| 05/27/2009 | CN100490802C Injection use medicine composition containing water-soluble 17-allylamino-17-demethoxy geldanamycin |
| 05/27/2009 | CN100490801C Ginkgolide B dropping pill and its preparing method |
| 05/27/2009 | CN100490798C Quick disintegrated tablet or oral cavity disintegrated tablet containing L-glutamic acid and azulene sodium sulfonate and making method thereof |
| 05/27/2009 | CN100490797C Pharmaceutical compositions |
| 05/27/2009 | CN100490796C Methodc for preparing sub-micron gemfibrozil medicament powder |
| 05/27/2009 | CN100490795C Red sage root salvianolic acid A injection formulation for treating cardiovascular diseases and preparation process thereof |
| 05/27/2009 | CN100490794C Lomustine liposome freeze-drying powder injection and its preparation method |
| 05/27/2009 | CN100490790C Enteric coated omeprazole pellets capsule and the preparing method thereof |
| 05/27/2009 | CN100490789C Enteric coated Chinese medicinal capsule for treating cancer and preparation method thereof |
| 05/27/2009 | CN100490788C American ginseng vitamine soft capsule |
| 05/27/2009 | CN100490787C Capsule for treating heart palpitation |
| 05/27/2009 | CN100490786C Chinese traditional medicine preparation for treating heart disease and preparation method |
| 05/27/2009 | CN100490785C Freeze-dried 'Shengmai' powder for injection and its preparing process |
| 05/27/2009 | CN100490784C Method for preparing protein or polypeptide medicine slow-releasing microball |
| 05/27/2009 | CN100490783C No-sugar Mailuoning granule and its preparing process and quality control method |
| 05/27/2009 | CN100490782C Methanesulfonic acid pazufloxacin gel droplet for ear and its preparation |
| 05/27/2009 | CN100490781C Pharmaceutical composition for treating qi and blood deficiency and its preparation method |
| 05/27/2009 | CN100490677C Nutritious tablet for female |
| 05/26/2009 | US7538125 Pioglitazone insulin sensitivity enhancer with the antidiabetic glimepiride; difference in mechanism of action avoids adverse reactions over long term use; oral dosage tablet; lactose excipient, hydroxypropylcellulose binder, magnesium stearate lubricant, calcium carbonate disintegrator; diabetes |
| 05/26/2009 | US7538094 Mixing ribavirin with excipient; pelletization; coating with material that reduces dissolution rate in water; sustained release, free-flowing |
| 05/26/2009 | US7538083 Compositions and methods for the potentiation of immune responses against target antigens |
| 05/26/2009 | US7537885 Composition for maintaining organ and cell viability |
| 05/26/2009 | US7537803 Polymer coating/encapsulation of nanoparticles using a supercritical antisolvent process |
| 05/26/2009 | US7537795 Agent is dissolved in water to form aqueous coating solution for coating extremely tiny skin piercing elements, solution is applied to skin piercing elements, dried, device is applied to skin of a living animal causing microprotrusions to pierce stratum corneum and deliver drug |
| 05/26/2009 | US7537788 Multilayer insert; radiopaque element, core, shell; controlling porosity of matrix |
| 05/26/2009 | US7537787 providing prolonged release of thyrotropin-releasing hormone in situ at the central nervous system locus over a period of time by in situ stereotaxic implantation |
| 05/26/2009 | US7537786 Complex of drug-carbon nanohorn and a process for producing the complex |
| 05/26/2009 | US7537785 Composition for treating vascular diseases characterized by nitric oxide insufficiency |
| 05/26/2009 | US7537784 Modified release tablet of bupropion hydrochloride |
| 05/26/2009 | US7537774 a mixture of catechol, croconic acid and/or sulfites, tetrahydroxyquinone and/or sulfites and acetogenins, in the form of a tablet, a capsule, a liquids, transdermal patches and gels, used for the treatment of colon cancer, autoimmune disease and viral diseases |
| 05/26/2009 | US7537754 Nontoxic, biocompatible water in oil emulsion with organic phase of ethenically unsaturated monomers or oligomers that does not provoke an autoimmune or inflammatory response for reforming damaged or diseased intervertebral discs by noninvasive means |
| 05/26/2009 | US7537752 Mixture of chelate compound and active material in vehicle |
| 05/26/2009 | US7537590 Multi-reservoir device for transdermal drug delivery and sensing |
| 05/26/2009 | US7537009 heating a substrate coated with formulation containing a drug ( e.g. antibiotics, antidepressants, antihistamines etc.) for a period of time, to form a vapor in less than 500 milliseconds, allowing the vapor to cool; absence of excipients |
| 05/26/2009 | CA2541498C Controlled release delivery system for nasal applications |
| 05/26/2009 | CA2494165C Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 05/26/2009 | CA2445478C Retinol derivatives potentiation of active substances by micellar preparation |
| 05/26/2009 | CA2440578C Oral peptide pharmaceutical dosage form and method of production |
| 05/26/2009 | CA2436668C Novel succinate salt of o-desmethyl-venlafaxine |
| 05/26/2009 | CA2436537C Pharmaceutical compositions comprising tiotropium salts and antihistamines |
| 05/26/2009 | CA2411754C 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents |
| 05/26/2009 | CA2399870C Topically applied clotting material |
| 05/26/2009 | CA2393072C Mono- and disaccharide derivatives |
| 05/26/2009 | CA2366702C Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| 05/26/2009 | CA2360418C Spheronised self-emulsifying system for hydrophobic and water-sensitive agents |
| 05/26/2009 | CA2355077C Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same |
| 05/26/2009 | CA2339495C Phospholipids with unsaturated alkyl and acyl chains |
| 05/26/2009 | CA2300932C Stabilized mixtures of an iodopropargyl compound and a formaldehyde donor |
| 05/26/2009 | CA2295512C Prostaglandin product |
| 05/26/2009 | CA2215254C Polyaminoacid-based particles for use as active principle vectors, and methods for preparing same |
| 05/26/2009 | CA2185893C Multilayered controlled release pharmaceutical dosage form |
| 05/26/2009 | CA2146783C Preparation of further diagnostic agents |
| 05/22/2009 | WO2009065130A2 Modified release formulations of diltiazem |
| 05/22/2009 | WO2009065077A1 Cationic-core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
| 05/22/2009 | WO2009065065A1 Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases |
| 05/22/2009 | WO2009064987A1 Granular nanoparticles having bright fluorescence and giant raman enhancements |
| 05/22/2009 | WO2009064928A1 Reduced dose intravenous acetaminophen |
| 05/22/2009 | WO2009064859A1 Process for manufacturing chewable dosage forms for drug delivery and products thereof |
| 05/22/2009 | WO2009064838A1 Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration |
| 05/22/2009 | WO2009064814A2 Tri-molecular complexes and their use in drug delivery systems |
| 05/22/2009 | WO2009064681A2 Liquid compositions comprising valsartan |
| 05/22/2009 | WO2009064469A1 Pulmonary delivery of a macrolide antibiotic |
| 05/22/2009 | WO2009064460A2 Gastrointestinal delivery systems |
| 05/22/2009 | WO2009064442A1 Viscous terpolymers as drug delivery platform |
| 05/22/2009 | WO2009064429A1 Water dispersible enteric coating formulation for nutraceutical and pharmaceutical dosage forms |
| 05/22/2009 | WO2009064374A2 Oral formulations of bis(thiohydrazide amides) |
| 05/22/2009 | WO2009064071A1 Controlled drug carrier for deliverying sildenafil citrate transdermally and patch containing the same |
| 05/22/2009 | WO2009063995A1 Diagnosis and treatment of arteriosclerosis |
| 05/22/2009 | WO2009063962A1 Fat emulsion containing medicinal agent, and process for production thereof |
| 05/22/2009 | WO2009063916A1 Aqueous film coating solution, film coating granule, and tablet comprising the film coating granule |
| 05/22/2009 | WO2009063491A2 Topical compositions for skincare |
| 05/22/2009 | WO2009063484A2 Stable pharmaceutical composition of lamotrigine |
| 05/22/2009 | WO2009063367A1 Dosage forms comprising celecoxib providing both rapid and sustained pain relief |
| 05/22/2009 | WO2009063320A2 Solid pharmaceutical composition of ded anosine |
| 05/22/2009 | WO2009063222A2 Solid compositions |
| 05/22/2009 | WO2009063116A1 Use of microparticles for vaccines and the release of biologically active molecules |
| 05/22/2009 | WO2009063021A1 Pharmaceutical forms for the release of active compounds |
| 05/22/2009 | WO2009062993A1 Pharmaceutical compositions |
| 05/22/2009 | WO2009062975A1 Aerogel compositions |
| 05/22/2009 | WO2009062683A1 C-19 steroids for therapeutic uses |
| 05/22/2009 | WO2009062518A1 Anti-fouling composition comprising an aerogel |
| 05/22/2009 | WO2009062399A1 Peptide ligand directed drug delivery |
| 05/22/2009 | WO2009062398A1 Novel thermosensitive liposomes containing therapeutic agents |
| 05/22/2009 | WO2009062368A1 A process of quality control for a capsule of treatment for prostatitis |
| 05/22/2009 | WO2009062356A1 Non-gelatin enteric hard capsule shell and preparation method thereof |
| 05/22/2009 | WO2009062299A1 Gel-stabilized liposome compositions, methods for their preparation and uses thereof |
| 05/22/2009 | WO2009062254A1 Device and method for preparing microparticles |
| 05/22/2009 | WO2009048945A8 Rapid mucosal gel or film insulin compositions |
| 05/22/2009 | WO2009034458A3 Oxygen permeable polymeric nanocontainers for encapsulation of sensitive compounds |
| 05/22/2009 | WO2009032994A3 Silica-based nanoparticles and methods of stimulating bone formation and suppressing bone resorption through modulation of nf-kb |
| 05/22/2009 | WO2009027866A3 Anti-microbial substrates with peroxide treatment |
| 05/22/2009 | WO2009013630A3 Hyperthermia devices and their uses with nanoparticles |
| 05/22/2009 | WO2009007622A3 Dermatological composition containing calcitriol lipidic vesicles, method for preparing same and use thereof |
| 05/22/2009 | WO2008157103A3 Modified release solid or semi-solid dosage forms |